CHARLES RIVER LABORATORIES INTERNATIONAL
Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different... strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services
CHARLES RIVER LABORATORIES INTERNATIONAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1947-01-01
Address:
Wilmington, Massachusetts, United States
Country:
United States
Website Url:
http://www.criver.com
Total Employee:
5001+
Status:
Active
Contact:
(781)222-6000
Total Funding:
1.53 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Euro
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-06 | Explora BioLabs | Explora BioLabs acquired by Charles River Laboratories International | 295 M USD |
| 2021-05-17 | Vigene Biosciences | Vigene Biosciences acquired by Charles River Laboratories International | 292.5 M USD |
| 2021-03-31 | Retrogenix | Retrogenix acquired by Charles River Laboratories International | N/A |
| 2021-02-17 | Cognate BioServices | Cognate BioServices acquired by Charles River Laboratories International | 875 M USD |
| 2020-12-31 | Distributed Bio | Distributed Bio acquired by Charles River Laboratories International | 83 M USD |
| 2020-08-06 | Cellero | Cellero acquired by Charles River Laboratories International | 38 M USD |
| 2019-12-16 | HemaCare | HemaCare acquired by Charles River Laboratories International | N/A |
| 2019-02-13 | CiToxLAB | CiToxLAB acquired by Charles River Laboratories International | 448 M EUR |
| 2018-02-13 | MPI Research | MPI Research acquired by Charles River Laboratories International | 800 M USD |
| 2018-01-11 | KWS BioTest | KWS BioTest acquired by Charles River Laboratories International | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Charles River Laboratories International
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Vernal Biosciences | Charles River Laboratories International investment in Venture Round - Vernal Biosciences | 21 M USD |
| 2022-05-19 | Deciphex | Charles River Laboratories International investment in Series B - Deciphex | 11.5 M USD |
| 2021-11-09 | PathoQuest | Charles River Laboratories International investment in Series B - PathoQuest | 15 M EUR |
| 2021-11-05 | bit.bio | Charles River Laboratories International investment in Series B - bit.bio | 103 M USD |
| 2019-09-06 | PathoQuest | Charles River Laboratories International investment in Venture Round - PathoQuest | 8 M EUR |
| 1997-01-01 | Aspect Medical Systems | Charles River Laboratories International investment in Venture Round - Aspect Medical Systems | 17.5 M USD |
Newest Events participated
Participated in Chemical Industry Regulations 2017
on 2017-09-05 as sponsor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as sponsor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.criver.com Semrush global rank: 252.54 K Semrush visits lastest month: 273.61 K
- Host name: ec2-52-54-40-78.compute-1.amazonaws.com
- IP address: 52.54.40.78
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Charles River Laboratories International"
Charles River Laboratories | Boldly challenge scientific possibility
Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.See details»
Our Story | Charles River
For more than 75 years, Charles River has delivered innovative solutions to our partners to accelerate the development of drugs, chemicals, and medical devices for the people and patients who need them.See details»
Charles River Laboratories - Wikipedia
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry (for eā¦See details»
Charles River Careers - Home
Find your moment to make a significant impact on global health with a career at Charles RiverSee details»
Charles River Laboratories Announces Organizational Changes to ā¦
WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 9, 2013-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced organizational changes which are designed ā¦See details»
Strategic Overview - Charles River Laboratories International, Inc.
The Leading, Early-Stage Contract Research Organization #1 Market position in RMS, Safety Assessment & Microbial Solutions >$15B Outsourced addressable market 4. ... See ā¦See details»
Investor Relations - Charles River Laboratories International, Inc.
WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 7, 2022-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2021 Corporate ā¦See details»
Charles River Laboratories - LinkedIn
Criver.com 19 Like Comment Share Charles River Laboratories ... The foundation is a Quebec non-profit organization that aims to improve care to Quebecers suffering from cancer, enhance the quality ...See details»
Research Scientist 1 - Sample Analysis, Shrewsbury, MA - Charles ā¦
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of ā¦See details»
Contract Manufacturing Organization - Charles River ā¦
Contract Manufacturing Organization Contract manufacturing organizations' work may involve performing the work in-house or using a trusted CRO to outsource testing to. Other options to consider are qualifying a vendor to handle overflow ā¦See details»
Client Coordinator, Montreal, QC - Charles Rivers Careers
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of ā¦See details»
Investor Relations - Charles River Laboratories International, Inc.
Feb 17, 2021 WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 17, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive ā¦See details»
Charles River Products and Services
Hover or click on the segments of this chart to explore our products and services.See details»
Drug Discovery Services | Charles River Laboratories
With >100 pre-clinical candidates delivered, >490 patents granted, and >270 peer reviewed co-authored publications, our unique combination of integrated, multidisciplinary drug discovery ā¦See details»
Charles River - Overview, News & Similar companies - ZoomInfo
Aug 25, 2024 Charles River contact info: Phone number: (781) 222-6000 Website: www.criver.com What does Charles River do? For more than 75 years, Charles River has ā¦See details»
Investor Relations - Charles River Laboratories International, Inc.
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers. ROCKVILLE, Md.--(BUSINESS WIRE)--Jun. 25, 2024-- Charles River Laboratories ā¦See details»
Vigene Biosciences Is Now Part of Charles River
Cell and Gene Therapy CDMO Facilities. Accelerate the development of your product and ensure it meets the highest regulatory standards while maintaining efficient production timelines ā¦See details»
A New Criver.com Experience | Charles River
Mar 28, 2024 A New Criver.com Experience Website upgrades are ongoing to help improve your experience Throughout 2024, users can expect to see enhancements across site content, ā¦See details»
Investor Relations - Charles River Laboratories International, Inc.
Feb 25, 2021 Implantable microdevice provides unique insight into individual and combination therapy efficacy during early-stage discovery. WILMINGTON, Mass.--(BUSINESS WIRE)- ā¦See details»